UK markets closed

Evogene Ltd. (EVGN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.6589+0.0087 (+1.34%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 34.14M
Enterprise value 14.58M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.34
Price/book (mrq)2.77
Enterprise value/revenue 2.59
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.16
52-week change 31.54%
S&P500 52-week change 326.49%
52-week high 31.4400
52-week low 30.4500
50-day moving average 30.7316
200-day moving average 30.7271

Share statistics

Avg vol (3-month) 3148.18k
Avg vol (10-day) 337.71k
Shares outstanding 550.66M
Implied shares outstanding 652.15M
Float 846.65M
% held by insiders 11.66%
% held by institutions 18.41%
Shares short (30 Apr 2024) 497.79k
Short ratio (30 Apr 2024) 41.41
Short % of float (30 Apr 2024) 40.19%
Short % of shares outstanding (30 Apr 2024) 40.19%
Shares short (prior month 28 Mar 2024) 486.45k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,319.72%

Management effectiveness

Return on assets (ttm)-30.90%
Return on equity (ttm)-81.78%

Income statement

Revenue (ttm)5.64M
Revenue per share (ttm)0.12
Quarterly revenue growth (yoy)-12.40%
Gross profit (ttm)N/A
EBITDA -24.7M
Net income avi to common (ttm)-23.88M
Diluted EPS (ttm)-0.5200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)31.06M
Total cash per share (mrq)0.61
Total debt (mrq)1.14M
Total debt/equity (mrq)3.97%
Current ratio (mrq)4.96
Book value per share (mrq)0.24

Cash flow statement

Operating cash flow (ttm)-21.58M
Levered free cash flow (ttm)-12.6M